New “First” Program: Six Months of Free Lab Space for Eligible First-Time Biotech Founders >

Search

Servier backs American startup’s research project at LabCentral

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

Read More

ReviveMed turns drug discovery into a big data problem and raises $1.5 M to solve it

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency

Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency

Pfizer Opens a Call For Proposals For LabCentral Residency

LabCentral "Golden Ticket" Submission

Aquinnah Pharmaceuticals Receives $3.4M Grant from NINDS To Advance New Therapies for ALS

Read More

After its recent funding round, HiFiBiO pens Takeda R&D collaboration